BONE INFARCTION IN A WOMAN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
Main Article Content
Abstract
Background: Bone infarction is characterized by death of the cellular elements of bone due to the compromise in the blood supply, which is classified into two main forms: post-traumatic and nontraumatic. A variety of systemic diseases and clinical conditions are associated with nontraumatic bone infarction. It is a severe complication in systemic lupus erythematosus (SLE) patients, which is strongly associated with corticosteroid use. Case report: We report a case of a 27-year-old woman diagnosed with SLE when she presented with severe acute knees pain (more serious in the left one). The counts of WBC and the level of CRP highly increased, the clinical diagnosis was osteomyelitis. Discussion: X-ray images of her shinbones and femur were normal but the magnetic resonance imaging showed bone infarction in the bilateral femur and in the upper end of the shinbones appropriate for early stage of bone infarction. Prolonged use of corticosteroid can lead to complications of bone infarction. Conclusion: Bone infacrtion is a common complication of systemic lupus erythematosus patients after prolonged treatment with high dose of corticosteroid. Magnetic resonance imaging is a paraclinical examination choosing to diagnose early stage of bone infarction.
Keywords
Osteonecrosis, bone infarction, systemic lupus erythematosus
Article Details
References
https://jcbsonline.ac.in/download-
article.php?Article_Unique_Id=JCBS327&Full_Text_Pdf_Download=True
2. Banu ORDAHAN, Ali Yavuz KARAHAN. Bone Infarctions in a Patient with Systemic Lupus
Erythematosus and Anti-phospholipid Syndrome. 2018. https://www.jpmrs.org/uploads/276683835786422.pdf
3. Zhao D, Zhang F, Wang B, Liu B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults. Journal of Orthopaedic Translation. 2019. 2020 Jan 6:21:100-110. DOI: 10.1016/j.jot.2019.12.004.
4. Gui-Qi Zhu, Hong-Xia Qiu, Xin-mei Ma, Mei-Xia Liu. Clinical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction. Int J Clin Pract. 2022. https://doi.org/10.1155/2022/7025811.
5. Zmerly H, Moscato M, Akkawi I, Galletti R, Di Gregori V. Treatment options for secondary osteonecrosis of the knee. Orthopedic Reviews. 2022. 14(2). Doi:10.52965/001c.33639.
6. Cheng Cheng, Can Huang, Zhen Chen, Feng Zhan, Xinwang Duan and “et al”. Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII. Arthritis Research & Therapy. 2023. Doi: 10.1186/s13075-023-03061-3.
7. Xin-Hui Xie, Xin-Luan Wang, Hui-Lin Yang, De-Wei Zhao, Ling Qin. Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview). J Orthop Translat. 2015 Jan 13. 3(2), 58–70. Doi:
10.1016/j.jot.2014.12.002.
8. Pepijn van Houten, Jacky de Rooy, Ingrid van der Geest, Romana Netea Maier, Annenienke van de Ven. Spontaneous bone infarction of the distal femur in a patient with Cushing's disease: a case report. Elsevier Bone Reports Volume 14, June 2021. 100756. https://doi.org/10.1016/j.bonr.2021.100756.
9. Christopher Chang, Adam Greenspan, M Eric Gershwin. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. Journal of Autoimmunity Volume 110, June 2020, 102460. https://doi.org/10.1016/j.jaut.2020.102460.
10. Mok MY, Farewell VT, Isenberg DA. Risk factors for avasculer necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis. 2000;59:462-7. Doi: 10.1136/ard.59.6.462.
11. Gladman, D. D., Dhillon, N., Su, J., & Urowitz, M. B. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus. 2018 Jan;27(1):76-81. Doi: 10.1177/0961203317711012.
12. Nagasawa K, Tada Y, Koarada S, et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus. 2005;14(5):385-90. Doi: 10.1191/0961203305lu2103oa.